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Background
Broad Gag recognition and polyfunctionality of vaccine-
induced AIDS virus-specific T cell responses correlate
with better viral control in non-human primates and
also in chronically HIV-infected individuals.
Methods
Breadth and polyfunctionality of HIV-vaccine induced
Gag-specific T cell responses were investigated in healthy
Tanzanian volunteers who participated in the Tanzania
Mozambique HIV vaccine trial (TaMoVac 01). Vaccine
recipients received 3x 0.6 or 1.0mg intradermal injections
of multiclade, multigene HIV-DNA vaccine boosted with
2x heterologous Modified Vaccinia Ankara (MVA)-
CMDR. Using fresh peripheral blood mononuclear cells,
the breadth of response was determined after the first
MVA-CMDR boost using peptide pools for 9 successive
Gag regions with an IFN-gamma ELISpot assay. Func-
tionality (IFN-gamma, IL-2, TNF-alpha, Mip-1beta and
the degranulation marker CD107) and phenotype (CD3,
CD4, CD8) of HIV-specific T cells were assessed using
flow cytometry in 52 participants after stimulation with
peptide pools covering whole Gag-CMDR protein.
Results
Two weeks after the first MVA-CMDR boost, a median of
2 Gag regions were recognized (range: 0-9, Placebos not
excluded) by 45 participants. There was a strong linear
correlation between the magnitude and the breadth of
vaccine-induced Gag recognition (p<0.0001, r2=0.44). 13
(25%), 13 (25%), 3 (6%) and 29 (56%) of 52 subjects
mounted IFN-gamma+ Gag-specific T cells that were
either only CD4+, CD4+ & CD8+, only CD8+, or CD4+
and/or CD8+, respectively. Fifty percent of IFN-gamma+
Gag-specific CD4 T cells co-expressed TNF-alpha and/or
IL-2. Co-expression of Mip-1beta or CD107 was reduced
compared to CMVpp65-specific CD4 T-cells, which were
measured simultaneously. More than 50% of IFN-gamma+
Gag-specific CD8 T-cells co-expressed CCR5 ligand Mip-
1beta and a large proportion of these had degranulated.
Conclusion
The TaMoVac-01 HIV-1 vaccine regimen induces a rela-
tively broad Gag-specific response frequently dominated
by CD4 T cells, many of which co-express IL-2 and/or
TNF-alpha, but also induces detectable Gag-specific CD8
T-cells in a third of vaccine recipients.
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